Overall Savings Generated by Generics and Biosimilars in 2021 #GRxBiosimsSavingsReport @accessiblemeds
Overall Savings Generated by Generics and Biosimilars in 2021 #GRxBiosimsSavingsReport  @accessiblemeds
Uploaded November 2022 | Updated November 2026, 15 hours ago
Generic and biosimilar medicines have generated more than $2.6 trillion in savings for patients over the past 10 years. With increased patient access, those savings will only continue to increase.

Learn more in our 2022 #GRxBiosims Savings Report: bit.ly/3UnZc7G
Overall Savings Generated by Generics and Biosimilars in 2021 #GRxBiosimsSavingsReportCOVID Response: AAM Board Chair Alok SonigAAM All Access Promo: Managing Drug Shortages Part 1Dougs Story - #medswithinreach35 Year Anniversary of Generic MedicinesGDUFA/BsUFA User Fees ExplainedSavings from Biosimilars since 2015 #GRxBiosimsSavingsReportBriefing: How NAFTA/Trade Policy Proposals Undermine Trump Administration Drug Pricing BlueprintAAM Lifetime Achievement Award - Joe RennerJoin us a GRx+Biosims 2021 — Progress + ProcessAAM Lifetime Achievement Award at Access! 2022GRx+Biosims 2022
Association for Accessible Medicines |

Overall Savings Generated by Generics and Biosimilars in 2021 #GRxBiosimsSavingsReport

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER